• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后的恶性肿瘤:EDTA-ERA注册研究经验。欧洲透析与移植协会-欧洲肾脏协会

Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association.

作者信息

Brunner F P, Landais P, Selwood N H

机构信息

St. Thomas Hospital.

出版信息

Nephrol Dial Transplant. 1995;10 Suppl 1:74-80. doi: 10.1093/ndt/10.supp1.74.

DOI:10.1093/ndt/10.supp1.74
PMID:7617285
Abstract

The incidence of malignancies in recipients of renal transplants was compared to that in non-grafted patients on maintenance dialysis as reported to the EDTA-ERA Registry and in the general population as recorded by the cancer registries of England and Wales, of Sweden, of the (former) German Democratic Republic, and of Lombardy and Varese in Northern Italy. For tumours known to be associated with immunosuppression, namely Kaposi's sarcoma, non-Hodgkin lymphoma and the common malignancies of the skin (except melanoma), an increased incidence was confirmed for the transplanted population. Thyroid carcinoma and hepatoma were found to be more frequent in non-grafted patients on dialysis as well as after renal transplantation. An increased incidence of cancer of the cervix and of the body of the uterus was recorded only for young cohorts with a functioning graft but not for women after menopause. Most of the other malignancies had similar incidences in grafted and non-grafted populations which did not differ from those in the general populations of the cancer registries except cancer of the colon which was slightly more frequent, particularly at 10-20 years after the first transplant operation. Survival after diagnosis of cancer at the most frequent sites, such as bronchopulmonary, breast, oesophagogastric and colorectal cancer, did not differ between non-grafted patient groups on dialysis and those who developed the tumour while carrying a functioning renal transplant.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

将接受肾移植者的恶性肿瘤发病率,与接受维持性透析的未移植患者(数据来自EDTA - ERA登记处)以及英格兰和威尔士、瑞典、(前)德意志民主共和国、意大利北部伦巴第和瓦雷泽的癌症登记处记录的普通人群的发病率进行了比较。对于已知与免疫抑制相关的肿瘤,即卡波西肉瘤、非霍奇金淋巴瘤和常见皮肤恶性肿瘤(黑色素瘤除外),移植人群的发病率有所增加。甲状腺癌和肝癌在接受透析的未移植患者以及肾移植后患者中更为常见。仅在移植功能正常的年轻队列中记录到宫颈癌和子宫体癌发病率增加,绝经后女性则未出现这种情况。大多数其他恶性肿瘤在移植和未移植人群中的发病率相似,与癌症登记处普通人群的发病率无异,但结肠癌略为常见,尤其是在首次移植手术后10至20年。在透析的未移植患者组和肾移植功能正常时患肿瘤的患者组中,支气管肺、乳腺、食管胃和结肠直肠癌等最常见部位癌症诊断后的生存率没有差异。(摘要截取自250字)

相似文献

1
Malignancies after renal transplantation: the EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association.肾移植后的恶性肿瘤:EDTA-ERA注册研究经验。欧洲透析与移植协会-欧洲肾脏协会
Nephrol Dial Transplant. 1995;10 Suppl 1:74-80. doi: 10.1093/ndt/10.supp1.74.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.肾替代治疗患者的感染和恶性肿瘤死亡率:来自 ERA-EDTA 登记处的数据。
Nephrol Dial Transplant. 2015 Jun;30(6):1028-37. doi: 10.1093/ndt/gfv007. Epub 2015 Jan 29.
4
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
5
Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.肉芽肿性多血管炎(韦格纳)和显微镜下多血管炎患者需要肾脏替代治疗的特征和结局:来自欧洲肾脏协会-欧洲透析和移植协会登记处的结果。
Am J Kidney Dis. 2015 Oct;66(4):613-20. doi: 10.1053/j.ajkd.2015.03.025. Epub 2015 May 12.
6
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.肝移植后新发肿瘤与意大利癌症登记处发病率的比较。
Dig Liver Dis. 2010 Jan;42(1):55-60. doi: 10.1016/j.dld.2009.04.017. Epub 2009 Jun 3.
7
Malignancies after renal transplantation in Taiwan: a nationwide population-based study.台湾地区肾移植后的恶性肿瘤:一项全国性基于人群的研究。
Nephrol Dial Transplant. 2012 Feb;27(2):833-9. doi: 10.1093/ndt/gfr277. Epub 2011 Jun 1.
8
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.肾移植失败后减少免疫抑制对癌症风险的影响:基于人群的回顾性队列研究。
BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.
9
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
10
Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry.通过小儿肾移植后移植失败风险识别亚组:生存树模型在ESPN/ERA-EDTA登记处的应用
Nephrol Dial Transplant. 2016 Feb;31(2):317-24. doi: 10.1093/ndt/gfv313. Epub 2015 Aug 27.

引用本文的文献

1
Immunosuppressant Drug Specific Risk of Malignancy After Organ Transplantation: A Population-Based Analysis of Texas Medicare Beneficiaries.器官移植后免疫抑制剂药物引发恶性肿瘤的特定风险:基于德克萨斯州医疗保险受益人的人群分析
Cancers (Basel). 2025 Jun 26;17(13):2161. doi: 10.3390/cancers17132161.
2
Increased Risk of Malignancy with Immunosuppression: A Population-Based Analysis of Texas Medicare Beneficiaries.免疫抑制导致恶性肿瘤风险增加:基于德克萨斯州医疗保险受益人的人群分析。
Cancers (Basel). 2023 Jun 11;15(12):3144. doi: 10.3390/cancers15123144.
3
Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study.
北欧肾移植受者的相对和绝对癌症风险:一项基于人群的研究。
Transpl Int. 2020 Dec;33(12):1700-1710. doi: 10.1111/tri.13734. Epub 2020 Sep 25.
4
Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis.肾移植后肾细胞癌的发病率和死亡率:一项荟萃分析。
J Clin Med. 2019 Apr 17;8(4):530. doi: 10.3390/jcm8040530.
5
Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation.实体器官移植后的结直肠癌特征与结局
J Oncol. 2019 Feb 28;2019:5796108. doi: 10.1155/2019/5796108. eCollection 2019.
6
Onco-nephrology: an appraisal of the cancer and chronic kidney disease links.肿瘤肾脏病学:对癌症与慢性肾脏病关联的评估
Nephrol Dial Transplant. 2015 Dec;30(12):1979-88. doi: 10.1093/ndt/gfu387. Epub 2015 Feb 3.
7
Outcomes of colorectal cancer arising in solid organ transplant recipients.实体器官移植受者发生结直肠癌的结局。
J Gastrointest Surg. 2014 Mar;18(3):599-604. doi: 10.1007/s11605-013-2402-3. Epub 2013 Nov 20.
8
Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients.肾移植受者子宫颈癌的发病率及临床病理行为。
World J Surg Oncol. 2011 Jul 13;9:72. doi: 10.1186/1477-7819-9-72.
9
Head and neck malignancies in Croatian renal transplant recipients.克罗地亚肾移植受者的头颈部恶性肿瘤。
Bosn J Basic Med Sci. 2010 Apr;10 Suppl 1(Suppl 1):S37-9. doi: 10.17305/bjbms.2010.2644.
10
Association of CKD and cancer risk in older people.老年人慢性肾脏病与癌症风险的关联
J Am Soc Nephrol. 2009 Jun;20(6):1341-50. doi: 10.1681/ASN.2008090998. Epub 2009 Apr 30.